This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision

Deerfield Management Company disclosed a buy of 418,538 shares of Vera Therapeutics (NASDAQ:VERA) in its February 17, 2026, SEC filing, with an estimated transaction value of $14.87 million based on the quarter’s average price. What happened According to a recent SEC filing, Deerfield Management Company increased its holding in Vera Therapeutics (NASDAQ:VERA) by 418,538 shares during the fourth quarter of 2025. The estimated transaction value, calculated using the period’s average closing price, was appr ...